During the experimentation, 3% of patients treated with MC experienced at least one serious ADR. The safety profile was dominated by neurological, gastrointestinal, and psychiatric ADRs. Only one case of MC misuse was identified with inflorescences. This study is observational and non-comparative and cannot provide a comprehensive assessment of the risk associated with MC use.
CBD reduces chronic pain in new randomized controlled trial
✦ New CED Clinical Relevance #82 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDPainResearch Why This Matters Clinicians can now cite higher-quality evidence when counseling patients with chronic...
Trump administration reclassifies cannabis in major shift that could expand scientific research – MSN
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Why This Matters Reclassification of cannabis to a lower Schedule could accelerate rigorous clinical...
Cannabis Balms for AIMSS: Clinical Trial Evidence
Clinical Takeaway A small clinical trial found that topical cannabis balms were safe and feasible for women with breast cancer experiencing joint and bone pain from aromatase inhibitor medications. The study demonstrates...
Endocannabinoid System Clinical Research: PTSD Treatment
Clinical Takeaway Trauma-focused treatments for PTSD combined with substance use disorders show comparable effectiveness whether or not patients use cannabis, based on analysis of clinical trial data. Active cannabis use does not...
Results from COSMOS trial reveals more than 75% of older adults have used …
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. AgingResearchSafety Dr. Caplan’s Take “What the COSMOS trial demonstrates is that cannabis use in older...
Marijuana – The Virginian-Pilot
✦ New CED Clinical Relevance #3 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchIndustry Clinical Perspective I’d be happy to write a clinical perspective paragraph, but I notice...
UNE to launch online program for cannabis certifications – WMUR
✦ New CED Clinical Relevance #5 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearch Clinical Summary The University of New England has launched an online certification program in...
The Des – In all, 24 states have passed legislation to legalize marijuana for recreational use …
✦ New CED Clinical Relevance #5 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustry Clinical Summary # Clinical Summary The expansion of recreational marijuana legalization across 24 states...
Opinion: Why are we not talking about weed? | Calgary Herald
✦ New CED Clinical Relevance #8 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyMental HealthIndustry Clinical Summary # Clinical Summary This opinion piece addresses the apparent reluctance among...